Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAR: Tarka vs Hyzaar in Metabolic Syndrome
NCT00234858Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of trandolapril + verapamil in hypertension (HTN) (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Oral Glucose Tolerance Test at 52 weeks. Started Mar 2004; status: completed.
02
Drugs
trandolapril + verapamil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00234858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234858.